$Cross Country Healthcare (CCRN.US)$ 🎯 On April 10, 2024, t...

New data: 4th quarter of 2023, continued comprehensive shrinkage.

In 2023, revenue shrank by 28%, operating profit shrank by 54.6% due to increased expense ratio, and net income shrank by 61.5%.

The asset-liability ratio decreased from 51.8% to 30.3%, total assets decreased significantly, and net assets slightly increased. On the asset side, accounts receivable decreased significantly, and on the liability side, long-term borrowings of 0.15 billion were eliminated, and accounts payable also decreased significantly. Overall, it has made deleveraging measures in response to business shrinkage.

Operating net cash flow is significantly higher than net investment, resulting in substantial shareholder surplus.

The current PE ratio is 8.6, and the valuation is not attractive relative to the current contraction trend. There is no need to adjust the position, only hold a small observation position.